{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:33:38Z","timestamp":1791405218189,"version":"4.3.3"},"reference-count":70,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2016.00396","type":"journal-article","created":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T03:04:03Z","timestamp":1477019043000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["Pharmacogenetics and Predictive Testing of Drug Hypersensitivity Reactions"],"prefix":"10.3389","volume":"7","author":[{"given":"Ruwen","family":"B\u00f6hm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingolf","family":"Cascorbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,10,21]]},"reference":[{"issue":"e47571","key":"B1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047571","article-title":"The diamine oxidase gene is associated with hypersensitivity response to non-steroidal anti-inflammatory drugs.","volume":"7","author":"Agundez","year":"2012","journal-title":"PLoS ONE"},{"issue":"586","key":"B2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.108.2.586","article-title":"Allopurinol and enalapril. Drug induced anaphylactic coronary spasm and acute myocardial infarction.","volume":"108","author":"Ahmad","year":"1995","journal-title":"Chest"},{"key":"B3","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2353\/jmoldx.2006.060022","article-title":"Molecular diagnosis of mast cell disorders: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology.","volume":"8","author":"Akin","year":"2006","journal-title":"J. Mol. Diagn."},{"key":"B4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/tpj.2015.39","article-title":"Cost-effectiveness of one-time genetic testing to minimize lifetime adverse drug reactions.","volume":"16","author":"Alagoz","year":"2016","journal-title":"Pharmacogenomics J."},{"key":"B5","doi-asserted-by":"publisher","first-page":"458","DOI":"10.4088\/JCP.09m05527yel","article-title":"Candidate gene analysis identifies a polymorphism in HLA-DQB1 associated with clozapine-induced agranulocytosis.","volume":"72","author":"Athanasiou","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.2217\/pgs.13.155","article-title":"Variability in histamine receptor genes HRH1, HRH2 and HRH4 in patients with hypersensitivity to NSAIDs.","volume":"14","author":"Ayuso","year":"2013","journal-title":"Pharmacogenomics"},{"key":"B7","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1055\/s-0029-1240002","article-title":"Epidemiology of idiosyncratic drug-induced liver injury.","volume":"29","author":"Bell","year":"2009","journal-title":"Semin. Liver Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1398-9995.2008.01924.x","article-title":"Update on the evaluation of hypersensitivity reactions to betalactams.","volume":"64","author":"Blanca","year":"2009","journal-title":"Allergy"},{"issue":"e0157753","key":"B9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157753","article-title":"Open vigil FDA - inspection of U.S. American adverse drug events pharmacovigilance data and novel clinical applications.","volume":"11","author":"B\u00f6hm","year":"2016","journal-title":"PLoS ONE"},{"key":"B10","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1001\/jama.205.9.645","article-title":"Assessment of adverse reactions within a drug surveillance program.","volume":"205","author":"Borda","year":"1968","journal-title":"JAMA"},{"key":"B11","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s40264-015-0281-0","article-title":"Epidemiology of adverse drug reactions in Europe: a review of recent observational studies.","volume":"38","author":"Bouvy","year":"2015","journal-title":"Drug Safety"},{"key":"B12","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/j.1399-0039.1996.tb02593.x","article-title":"Comparison of HLA-A antigen typing by serology with two polymerase chain reaction based DNA typing methods: implications for proficiency testing.","volume":"47","author":"Bozon","year":"1996","journal-title":"Tissue Antigens"},{"key":"B13","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1067\/mcp.2002.127494","article-title":"The impact of the CYP2D6 polymorphism on haloperidol pharmacokinetics and on the outcome of haloperidol treatment.","volume":"72","author":"Brockmoller","year":"2002","journal-title":"Clin. Pharmacol. Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/ACI.0b013e32832db943","article-title":"Selective immediate hypersensitivity reactions to NSAIDs.","volume":"9","author":"Canto","year":"2009","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1136\/archdischild-2015-310364","article-title":"QUESTION 2: does amoxicillin exposure increase the risk of rash in children with acute Epstein-Barr virus infection?","volume":"101","author":"Chew","year":"2016","journal-title":"Arch. Dis. Childhood"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1002\/humu.21579","article-title":"A functional XPNPEP2 promoter haplotype leads to reduced plasma aminopeptidase P and increased risk of ACE inhibitor-induced angioedema.","volume":"32","author":"Cilia La Corte","year":"2011","journal-title":"Hum. Mutat."},{"key":"B17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nri981","article-title":"Hepatic T cells and liver tolerance.","volume":"3","author":"Crispe","year":"2003","journal-title":"Nature Reviews. Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ng.379","article-title":"HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.","volume":"41","author":"Daly","year":"2009","journal-title":"Nat. Genet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1034\/j.1398-9995.1999.00020.x","article-title":"Predictive capacity of histamine release for the diagnosis of drug allergy.","volume":"54","author":"Demoly","year":"1999","journal-title":"Allergy"},{"key":"B20","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/sj.tpj.6500423","article-title":"Clozapine-induced agranulocytosis in schizophrenic Caucasians: confirming clues for associations with human leukocyte class I and II antigens.","volume":"7","author":"Dettling","year":"2007","journal-title":"Pharmacogenomics J."},{"key":"B21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1001\/archpsyc.58.1.93","article-title":"Genetic determinants of clozapine-induced agranulocytosis: recent results of HLA subtyping in a non-jewish caucasian sample.","volume":"58","author":"Dettling","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"B22","first-page":"363","article-title":"Drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients.","volume":"22","author":"Dona","year":"2012","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.2217\/bmm.15.98","article-title":"HLADR: a database system for enhancing the discovery of biomarkers for predicting human leukocyte antigen-mediated idiosyncratic adverse drug reactions.","volume":"9","author":"Du","year":"2015","journal-title":"Biomark. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1086\/301676","article-title":"Familial progressive sensorineural deafness is mainly due to the mtDNA A1555G mutation and is enhanced by treatment of aminoglycosides.","volume":"62","author":"Estivill","year":"1998","journal-title":"Am. J. Hum. Genet."},{"issue":"4757","key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5757","article-title":"Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles.","volume":"5","author":"Goldstein","year":"2014","journal-title":"Nat. Commun."},{"key":"B26","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/ACI.0000000000000178","article-title":"Genetic basis of hypersensitivity reactions to nonsteroidal anti-inflammatory drugs.","volume":"15","author":"Gomez","year":"2015","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jaci.2014.07.047","article-title":"HLA-DRA variants predict penicillin allergy in genome-wide fine-mapping genotyping.","volume":"135","author":"Gueant","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1093\/clinids\/13.4.697","article-title":"Adverse virus-drug interactions.","volume":"13","author":"Haverkos","year":"1991","journal-title":"Rev. Infect. Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00228-014-1777-8","article-title":"Metamizole-induced agranulocytosis revisited: results from the prospective Berlin case-control surveillance study.","volume":"71","author":"Huber","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1200\/JCO.2008.20.6300","article-title":"Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics.","volume":"27","author":"Innocenti","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/S0140-6736(83)90627-X","article-title":"Complications of co-trimoxazole in treatment of AIDS-associated Pneumocystis carinii pneumonia in homosexual men.","volume":"2","author":"Jaffe","year":"1983","journal-title":"Lancet"},{"key":"B32","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1365-2222.2006.02457.x","article-title":"Cysteinyl leukotriene receptor 1 promoter polymorphism is associated with aspirin-intolerant asthma in males.","volume":"36","author":"Kim","year":"2006","journal-title":"Clin. Exp. Allergy"},{"key":"B33","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1001\/archpsyc.1990.01810220061007","article-title":"HLA-B38, DR4, DQw3 and clozapine-induced agranulocytosis in Jewish patients with schizophrenia.","volume":"47","author":"Lieberman","year":"1990","journal-title":"Arch. Gen. Psychiatry"},{"key":"B34","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2217\/pgs.12.206","article-title":"Pharmacogenetics of ACE inhibitor-induced angioedema and cough: a systematic review and meta-analysis.","volume":"14","author":"Mahmoudpour","year":"2013","journal-title":"Pharmacogenomics"},{"key":"B35","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0140-6736(02)07873-X","article-title":"Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir.","volume":"359","author":"Mallal","year":"2002","journal-title":"Lancet"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/j.1528-1167.2007.01022.x","article-title":"Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese.","volume":"48","author":"Man","year":"2007","journal-title":"Epilepsia"},{"key":"B37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/BF01570478","article-title":"Basal serum IgE levels and HLA antigen frequencies in allergic subjects.","volume":"5","author":"Marsh","year":"1977","journal-title":"Immunogenetics"},{"key":"B38","doi-asserted-by":"publisher","first-page":"4180","DOI":"10.1073\/pnas.0307067101","article-title":"Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant.","volume":"101","author":"Martin","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B39","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/clpt.2014.38","article-title":"Clinical pharmacogenetics implementation consortium guidelines for HLA-B genotype and abacavir dosing: 2014 update.","volume":"95","author":"Martin","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"B40","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/clpt.2011.355","article-title":"Clinical pharmacogenetics implementation consortium guidelines for HLA-B genotype and abacavir dosing.","volume":"91","author":"Martin","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1056\/NEJMoa1013297","article-title":"HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans.","volume":"364","author":"McCormack","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/pds.3663","article-title":"Adverse drug events in patients admitted to an emergency department: an analysis of direct costs.","volume":"24","author":"Meier","year":"2015","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"B43","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/pds.667","article-title":"Adverse drug reactions as a cause for admissions to a department of internal medicine.","volume":"11","author":"Mjorndal","year":"2002","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"B44","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1097\/00005537-200003000-00017","article-title":"HLA-DRB1, -DQA1, and -DQB1 genotypes in patients with nasal polyposis.","volume":"110","author":"Molnar-Gabor","year":"2000","journal-title":"Laryngoscope"},{"key":"B45","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/INF.0b013e31824e10d7","article-title":"Defining risk factors for red man syndrome in children and adults.","volume":"31","author":"Myers","year":"2012","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B46","doi-asserted-by":"publisher","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","article-title":"Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.","volume":"92","author":"Nagata","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B47","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/FPC.0000000000000209","article-title":"HLA-DRB1*16: 01-DQB1*05: 02 is a novel genetic risk factor for flupirtine-induced liver injury.","volume":"26","author":"Nicoletti","year":"2016","journal-title":"Pharmacogenetics Genom."},{"key":"B48","doi-asserted-by":"publisher","first-page":"258","DOI":"10.4168\/aair.2013.5.5.258","article-title":"Unraveling the genetic basis of aspirin hypersensitivity in asthma beyond arachidonate pathways.","volume":"5","author":"Park","year":"2013","journal-title":"Allergy Asthma Immunol. Res."},{"issue":"463","key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)91807-5","article-title":"Fatal stevens-johnson syndrome in a patient on captopril and allopurinol.","volume":"1","author":"Pennell","year":"1984","journal-title":"Lancet"},{"key":"B50","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1016\/j.jaci.2010.11.046","article-title":"Drug hypersensitivity: pharmacogenetics and clinical syndromes.","volume":"127","author":"Phillips","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1309\/AJCPBVLJZH6W6RQM","article-title":"Pathology consultation on drug-induced hemolytic anemia.","volume":"136","author":"Pierce","year":"2011","journal-title":"Am. J. Clin. Pathol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jaci.2015.06.022","article-title":"New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivity.","volume":"136","author":"Pirmohamed","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1128\/AAC.37.10.2139","article-title":"Vancomycin skin tests and prediction of \u201cred man syndrome\u201d in healthy volunteers.","volume":"37","author":"Polk","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"B54","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1111\/j.1365-2222.2007.02742.x","article-title":"Delayed drug hypersensitivity reactions - new concepts.","volume":"37","author":"Posadas","year":"2007","journal-title":"Clin. Exp. Allergy"},{"key":"B55","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/00042560-199502000-00004","article-title":"Toxicity of sulfonamide-reactive metabolites in HIV-infected, HTLV-infected, and noninfected cells.","volume":"8","author":"Rieder","year":"1995","journal-title":"J. Acquired Immune Defic. Syndr. Hum. Retrovirol."},{"key":"B56","first-page":"15","article-title":"Testing for drug hypersensitivity syndromes.","volume":"34","author":"Rive","year":"2013","journal-title":"Clin. Biochemist. Rev."},{"key":"B57","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1128\/AAC.34.5.765","article-title":"Comparison of vancomycin- and teicoplanin-induced histamine release and \u201cred man syndrome\u201d.","volume":"34","author":"Sahai","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"key":"B58","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/cc1871","article-title":"Red man syndrome.","volume":"7","author":"Sivagnanam","year":"2003","journal-title":"Crit. Care"},{"issue":"e68111","key":"B59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068111","article-title":"HLA alleles influence the clinical signature of amoxicillin-clavulanate hepatotoxicity.","volume":"8","author":"Stephens","year":"2013","journal-title":"PLoS ONE"},{"key":"B60","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ejmg.2016.04.002","article-title":"A template for broad consent in biobank research. Results and explanation of an evidence and consensus-based development process.","volume":"59","author":"Strech","year":"2016","journal-title":"Eur. J. Med. Genet."},{"key":"B61","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/j.1365-2230.2007.02488.x","article-title":"Statin-induced Ro\/SSa-positive subacute cutaneous lupus erythematosus.","volume":"32","author":"Suchak","year":"2007","journal-title":"Clin. Exp. Dermatol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"490","DOI":"10.7326\/0003-4819-124-5-199603010-00005","article-title":"Association between the DRB1*08032 histocompatibility antigen and methimazole-induced agranulocytosis in Japanese patients with Graves disease.","volume":"124","author":"Tamai","year":"1996","journal-title":"Ann. Intern. Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/ajh.21433","article-title":"Idiosyncratic drug-induced agranulocytosis: possible mechanisms and management.","volume":"84","author":"Tesfa","year":"2009","journal-title":"Am. J. Hematol."},{"key":"B64","doi-asserted-by":"crossref","first-page":"333","DOI":"10.5694\/j.1326-5377.2006.tb00591.x","article-title":"3. Drug hypersensitivity.","volume":"185","author":"Thien","year":"2006","journal-title":"Med. J. Aust."},{"key":"B65","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0021-9924(98)00014-8","article-title":"Sensorineural hearing loss caused by mitochondrial DNA mutations: special reference to the A1555G mutation.","volume":"31","author":"Usami","year":"1998","journal-title":"J. Commun. Disord."},{"key":"B66","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/00008571-199602000-00005","article-title":"Genetic factors and risk of agranulocytosis from metamizol.","volume":"6","author":"Vlahov","year":"1996","journal-title":"Pharmacogenetics"},{"issue":"e478","key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.02.036","article-title":"Promiscuous T-cell responses to drugs and drug-haptens.","volume":"136","author":"Yaseen","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1164\/ajrccm.151.1.7812558","article-title":"The association of HLA-DR3 with specific IgE to inhaled acid anhydrides.","volume":"151","author":"Young","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B69","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.schres.2014.06.003","article-title":"Polycystic ovaries is a disproportionate signal in pharmacovigilance data mining of second generation antipsychotics.","volume":"158","author":"Yum","year":"2014","journal-title":"Schizophr. Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/ijd.12570","article-title":"Association of HLA-B*1502 allele with lamotrigine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in han Chinese subjects: a meta-analysis.","volume":"54","author":"Zeng","year":"2015","journal-title":"Int. J. Dermatol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2016.00396\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T20:52:20Z","timestamp":1601153540000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2016.00396\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,21]]},"references-count":70,"URL":"https:\/\/doi.org\/10.3389\/fphar.2016.00396","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,21]]}}}